195 related articles for article (PubMed ID: 37314582)
1. Epidemiology of Invasive Candidiasis in Patients with Hematologic Malignancy on Antifungal Prophylaxis.
McCort ME; Tsai H
Mycopathologia; 2023 Dec; 188(6):885-892. PubMed ID: 37314582
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.
Pfaller MA; Andes DR; Diekema DJ; Horn DL; Reboli AC; Rotstein C; Franks B; Azie NE
PLoS One; 2014; 9(7):e101510. PubMed ID: 24991967
[TBL] [Abstract][Full Text] [Related]
3. Update on invasive fungal disease.
Pagano L; Lumb J
Future Microbiol; 2011 Sep; 6(9):985-9. PubMed ID: 21958139
[TBL] [Abstract][Full Text] [Related]
4. The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multiresistant Candida auris.
Quindós G; Marcos-Arias C; San-Millán R; Mateo E; Eraso E
Int Microbiol; 2018 Sep; 21(3):107-119. PubMed ID: 30810955
[TBL] [Abstract][Full Text] [Related]
5. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
6. Effect of coccidioidomycosis prophylaxis in selecting non-Candida albicans species amongst solid organ transplant recipients in Arizona.
Al-Obaidi MM; Marquez J; Afghan A; Zangeneh TT
Mycoses; 2023 Mar; 66(3):237-241. PubMed ID: 36401812
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, antifungal susceptibilities, and risk factors for invasive candidiasis from 2011 to 2013 in a teaching hospital in southwest China.
Pu S; Niu S; Zhang C; Xu X; Qin M; Huang S; Zhang L
J Microbiol Immunol Infect; 2017 Feb; 50(1):97-103. PubMed ID: 25769664
[TBL] [Abstract][Full Text] [Related]
8. [Invasive candidiasis after hematopoietic cell transplantation].
Kimura SI
Rinsho Ketsueki; 2023; 64(9):1176-1183. PubMed ID: 37899198
[TBL] [Abstract][Full Text] [Related]
9. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection.
Sipsas NV; Lewis RE; Tarrand J; Hachem R; Rolston KV; Raad II; Kontoyiannis DP
Cancer; 2009 Oct; 115(20):4745-52. PubMed ID: 19634156
[TBL] [Abstract][Full Text] [Related]
10. Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis.
Xin H; Rosario-Colon JA; Eberle K
mSphere; 2023 Feb; 8(1):e0058422. PubMed ID: 36688668
[TBL] [Abstract][Full Text] [Related]
11. Approaches to the early treatment of invasive fungal infection.
Ito JI; Kriengkauykiat J; Dadwal SS; Arfons LM; Lazarus HM
Leuk Lymphoma; 2010 Sep; 51(9):1623-31. PubMed ID: 20629521
[TBL] [Abstract][Full Text] [Related]
12. Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units.
Shahin J; Allen EJ; Patel K; Muskett H; Harvey SE; Edgeworth J; Kibbler CC; Barnes RA; Biswas S; Soni N; Rowan KM; Harrison DA;
BMC Infect Dis; 2016 Sep; 16(1):480. PubMed ID: 27612566
[TBL] [Abstract][Full Text] [Related]
13. Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients.
Bays DJ; Thompson GR
Infect Dis Clin North Am; 2019 Jun; 33(2):545-566. PubMed ID: 31005138
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of candidaemia and invasive candidiasis. A changing face.
Quindós G
Rev Iberoam Micol; 2014; 31(1):42-8. PubMed ID: 24270071
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology of Candida species in the Middle East and North Africa.
Ghazi S; Rafei R; Osman M; El Safadi D; Mallat H; Papon N; Dabboussi F; Bouchara JP; Hamze M
J Mycol Med; 2019 Sep; 29(3):245-252. PubMed ID: 31400864
[TBL] [Abstract][Full Text] [Related]
16. Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species.
Ou HT; Lee TY; Chen YC; Charbonneau C
BMC Infect Dis; 2017 Jul; 17(1):481. PubMed ID: 28693479
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?
Soulountsi V; Schizodimos T; Kotoulas SC
Infection; 2021 Dec; 49(6):1107-1131. PubMed ID: 34132989
[TBL] [Abstract][Full Text] [Related]
18. The current treatment landscape: candidiasis.
Bassetti M; Peghin M; Timsit JF
J Antimicrob Chemother; 2016 Nov; 71(suppl 2):ii13-ii22. PubMed ID: 27880665
[TBL] [Abstract][Full Text] [Related]
19. Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis.
Posteraro B; De Carolis E; Criscuolo M; Ballanti S; De Angelis G; Del Principe MI; Delia M; Fracchiolla N; Marchesi F; Nadali G; Picardi M; Piccioni AL; Verga L; Candoni A; Busca A; Sanguinetti M; Pagano L;
Mycoses; 2020 Sep; 63(9):900-910. PubMed ID: 32531854
[TBL] [Abstract][Full Text] [Related]
20. Candidemia and invasive candidiasis in adults: A narrative review.
Antinori S; Milazzo L; Sollima S; Galli M; Corbellino M
Eur J Intern Med; 2016 Oct; 34():21-28. PubMed ID: 27394927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
